Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Key players in the plasma protein therapeutics market engage in regulatory approvals, technologically advanced products, new product launches, and acquisitions and collaboration agreements with other companies. The Plasma Protein Therapeutics Market is projected to expand at a CAGR of 7.1% from 2020 to 2026.
The plasma protein therapeutics market will be driven by growing Investment in Innovation, rising demand for Immunoglobulin (IG), rising use of plasma derived protein therapeutics. The rising incidence of more than 200 diseases affecting the immune or nervous systems is driving the market. However, strict regulations and cost reimbursement, rates of biologic diagnosis, and high prices are major market barriers.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Plasma Protein Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Plasma Protein Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Plasma Protein Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Octapharma
Biotest
LFB Group
Shire (Baxalta)
BPL
Hualan Bio
Kamada
Kedrion
RAAS
CSL
CBPO
Grifols
By Type:
Coagulation Factor
Immune Globulin
Albumin
Others
By End-User:
Hemophilia
PID
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Plasma Protein Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Plasma Protein Therapeutics Market Size and Growth Rate of Coagulation Factor from 2016 to 2027
-
1.3.2 China Plasma Protein Therapeutics Market Size and Growth Rate of Immune Globulin from 2016 to 2027
-
1.3.3 China Plasma Protein Therapeutics Market Size and Growth Rate of Albumin from 2016 to 2027
-
1.3.4 China Plasma Protein Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Plasma Protein Therapeutics Market Size and Growth Rate of Hemophilia from 2016 to 2027
-
1.4.2 China Plasma Protein Therapeutics Market Size and Growth Rate of PID from 2016 to 2027
-
1.4.3 China Plasma Protein Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Plasma Protein Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Plasma Protein Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Coagulation Factor
-
3.4.2 Market Size and Growth Rate of Immune Globulin
-
3.4.3 Market Size and Growth Rate of Albumin
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Plasma Protein Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Plasma Protein Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Plasma Protein Therapeutics in Hemophilia
-
4.4.2 Market Size and Growth Rate of Plasma Protein Therapeutics in PID
-
4.4.3 Market Size and Growth Rate of Plasma Protein Therapeutics in Others
5 Market Analysis by Regions
-
5.1 China Plasma Protein Therapeutics Production Analysis by Regions
-
5.2 China Plasma Protein Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Plasma Protein Therapeutics Landscape Analysis
-
6.1 North China Plasma Protein Therapeutics Landscape Analysis by Major Types
-
6.2 North China Plasma Protein Therapeutics Landscape Analysis by Major End-Users
7 Central China Plasma Protein Therapeutics Landscape Analysis
-
7.1 Central China Plasma Protein Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Plasma Protein Therapeutics Landscape Analysis by Major End-Users
8 South China Plasma Protein Therapeutics Landscape Analysis
-
8.1 South China Plasma Protein Therapeutics Landscape Analysis by Major Types
-
8.2 South China Plasma Protein Therapeutics Landscape Analysis by Major End-Users
9 East China Plasma Protein Therapeutics Landscape Analysis
-
9.1 East China Plasma Protein Therapeutics Landscape Analysis by Major Types
-
9.2 East China Plasma Protein Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Plasma Protein Therapeutics Landscape Analysis
-
10.1 Northeast China Plasma Protein Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Plasma Protein Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Plasma Protein Therapeutics Landscape Analysis
-
11.1 Southwest China Plasma Protein Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Plasma Protein Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Plasma Protein Therapeutics Landscape Analysis
-
12.1 Northwest China Plasma Protein Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Plasma Protein Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Octapharma
-
13.1.1 Octapharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Biotest
-
13.2.1 Biotest Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 LFB Group
-
13.3.1 LFB Group Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Shire (Baxalta)
-
13.4.1 Shire (Baxalta) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 BPL
-
13.5.1 BPL Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Hualan Bio
-
13.6.1 Hualan Bio Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Kamada
-
13.7.1 Kamada Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Kedrion
-
13.8.1 Kedrion Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 RAAS
-
13.9.1 RAAS Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 CSL
-
13.10.1 CSL Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 CBPO
-
13.11.1 CBPO Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Grifols
-
13.12.1 Grifols Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Plasma Protein Therapeutics Market Size and Growth Rate of Coagulation Factor from 2016 to 2027
-
Figure China Plasma Protein Therapeutics Market Size and Growth Rate of Immune Globulin from 2016 to 2027
-
Figure China Plasma Protein Therapeutics Market Size and Growth Rate of Albumin from 2016 to 2027
-
Figure China Plasma Protein Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Plasma Protein Therapeutics Market Size and Growth Rate of Hemophilia from 2016 to 2027
-
Figure China Plasma Protein Therapeutics Market Size and Growth Rate of PID from 2016 to 2027
-
Figure China Plasma Protein Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Plasma Protein Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Plasma Protein Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Plasma Protein Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Plasma Protein Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Plasma Protein Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Coagulation Factor
-
Figure Market Size and Growth Rate of Immune Globulin
-
Figure Market Size and Growth Rate of Albumin
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Plasma Protein Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Plasma Protein Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hemophilia
-
Figure Market Size and Growth Rate of PID
-
Figure Market Size and Growth Rate of Others
-
Table China Plasma Protein Therapeutics Production by Regions
-
Table China Plasma Protein Therapeutics Production Share by Regions
-
Figure China Plasma Protein Therapeutics Production Share by Regions in 2016
-
Figure China Plasma Protein Therapeutics Production Share by Regions in 2021
-
Figure China Plasma Protein Therapeutics Production Share by Regions in 2027
-
Table China Plasma Protein Therapeutics Consumption by Regions
-
Table China Plasma Protein Therapeutics Consumption Share by Regions
-
Figure China Plasma Protein Therapeutics Consumption Share by Regions in 2016
-
Figure China Plasma Protein Therapeutics Consumption Share by Regions in 2021
-
Figure China Plasma Protein Therapeutics Consumption Share by Regions in 2027
-
Table North China Plasma Protein Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Plasma Protein Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Plasma Protein Therapeutics Consumption Share by Types in 2016
-
Figure North China Plasma Protein Therapeutics Consumption Share by Types in 2021
-
Figure North China Plasma Protein Therapeutics Consumption Share by Types in 2027
-
Table North China Plasma Protein Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Plasma Protein Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Plasma Protein Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Plasma Protein Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Plasma Protein Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Plasma Protein Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Plasma Protein Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Plasma Protein Therapeutics Consumption Share by Types in 2016
-
Figure Central China Plasma Protein Therapeutics Consumption Share by Types in 2021
-
Figure Central China Plasma Protein Therapeutics Consumption Share by Types in 2027
-
Table Central China Plasma Protein Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Plasma Protein Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Plasma Protein Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Plasma Protein Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Plasma Protein Therapeutics Consumption Share by End-Users in 2027
-
Table South China Plasma Protein Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Plasma Protein Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Plasma Protein Therapeutics Consumption Share by Types in 2016
-
Figure South China Plasma Protein Therapeutics Consumption Share by Types in 2021
-
Figure South China Plasma Protein Therapeutics Consumption Share by Types in 2027
-
Table South China Plasma Protein Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Plasma Protein Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Plasma Protein Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Plasma Protein Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Plasma Protein Therapeutics Consumption Share by End-Users in 2027
-
Table East China Plasma Protein Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Plasma Protein Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Plasma Protein Therapeutics Consumption Share by Types in 2016
-
Figure East China Plasma Protein Therapeutics Consumption Share by Types in 2021
-
Figure East China Plasma Protein Therapeutics Consumption Share by Types in 2027
-
Table East China Plasma Protein Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Plasma Protein Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Plasma Protein Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Plasma Protein Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Plasma Protein Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Plasma Protein Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Plasma Protein Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Plasma Protein Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Plasma Protein Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Plasma Protein Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Plasma Protein Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Plasma Protein Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Plasma Protein Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Plasma Protein Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Plasma Protein Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Plasma Protein Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Plasma Protein Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Plasma Protein Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Plasma Protein Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Plasma Protein Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Plasma Protein Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Plasma Protein Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Plasma Protein Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Plasma Protein Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Plasma Protein Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Plasma Protein Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Plasma Protein Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Plasma Protein Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Plasma Protein Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Plasma Protein Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Plasma Protein Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Plasma Protein Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Plasma Protein Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Plasma Protein Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Plasma Protein Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Octapharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma
-
Figure Sales and Growth Rate Analysis of Octapharma
-
Figure Revenue and Market Share Analysis of Octapharma
-
Table Product and Service Introduction of Octapharma
-
Table Company Profile and Development Status of Biotest
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest
-
Figure Sales and Growth Rate Analysis of Biotest
-
Figure Revenue and Market Share Analysis of Biotest
-
Table Product and Service Introduction of Biotest
-
Table Company Profile and Development Status of LFB Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LFB Group
-
Figure Sales and Growth Rate Analysis of LFB Group
-
Figure Revenue and Market Share Analysis of LFB Group
-
Table Product and Service Introduction of LFB Group
-
Table Company Profile and Development Status of Shire (Baxalta)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire (Baxalta)
-
Figure Sales and Growth Rate Analysis of Shire (Baxalta)
-
Figure Revenue and Market Share Analysis of Shire (Baxalta)
-
Table Product and Service Introduction of Shire (Baxalta)
-
Table Company Profile and Development Status of BPL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BPL
-
Figure Sales and Growth Rate Analysis of BPL
-
Figure Revenue and Market Share Analysis of BPL
-
Table Product and Service Introduction of BPL
-
Table Company Profile and Development Status of Hualan Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio
-
Figure Sales and Growth Rate Analysis of Hualan Bio
-
Figure Revenue and Market Share Analysis of Hualan Bio
-
Table Product and Service Introduction of Hualan Bio
-
Table Company Profile and Development Status of Kamada
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamada
-
Figure Sales and Growth Rate Analysis of Kamada
-
Figure Revenue and Market Share Analysis of Kamada
-
Table Product and Service Introduction of Kamada
-
Table Company Profile and Development Status of Kedrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion
-
Figure Sales and Growth Rate Analysis of Kedrion
-
Figure Revenue and Market Share Analysis of Kedrion
-
Table Product and Service Introduction of Kedrion
-
Table Company Profile and Development Status of RAAS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RAAS
-
Figure Sales and Growth Rate Analysis of RAAS
-
Figure Revenue and Market Share Analysis of RAAS
-
Table Product and Service Introduction of RAAS
-
Table Company Profile and Development Status of CSL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL
-
Figure Sales and Growth Rate Analysis of CSL
-
Figure Revenue and Market Share Analysis of CSL
-
Table Product and Service Introduction of CSL
-
Table Company Profile and Development Status of CBPO
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CBPO
-
Figure Sales and Growth Rate Analysis of CBPO
-
Figure Revenue and Market Share Analysis of CBPO
-
Table Product and Service Introduction of CBPO
-
Table Company Profile and Development Status of Grifols
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols
-
Figure Sales and Growth Rate Analysis of Grifols
-
Figure Revenue and Market Share Analysis of Grifols
-
Table Product and Service Introduction of Grifols
-
